Print

Onconova Therapeutics Inc. Appoints Dr. Thomas J. McKearn as President, Research and Development  
10/9/2012 10:35:24 AM

NEWTOWN, Pa. & PENNINGTON, N.J.--(BUSINESS WIRE)--Onconova Therapeutics, Inc. today announced the appointment of Thomas J. McKearn, M.D., Ph.D. as President, Research and Development. Dr. McKearn is a veteran drug development executive who most recently served as Vice President, Strategic Clinical Affairs at Agennix, Inc. “Thomas brings substantial leadership experience in all key aspects of drug development to Onconova, including research, clinical development, business operations, and corporate development,” said Ramesh Kumar, Chief Executive Officer of Onconova. “I am very pleased to welcome him to our executive team and look forward to his contributions as the Phase III trial of rigosertib in Myelodysplastic Syndromes progresses toward pivotal data in 2013.”
//-->